| Type | Sym | Class | Transaction | Value $ | Shares | Change % | Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | ISRG | Common Stock | Options Exercise | $214K | +3K | +12.35% | $71.32 | 27.3K | Oct 22, 2021 | Direct | F1, F2 |
| transaction | ISRG | Common Stock | Sale | -$1.02M | -3K | -11% | $339.64 | 24.3K | Oct 22, 2021 | Direct | F1, F2, F3 |
| transaction | ISRG | Common Stock | Options Exercise | $256K | +4.5K | +18.53% | $56.97 | 28.8K | Oct 22, 2021 | Direct | F1, F2 |
| transaction | ISRG | Common Stock | Sale | -$1.53M | -4.5K | -15.63% | $339.64 | 24.3K | Oct 22, 2021 | Direct | F1, F2, F3 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | ISRG | Non-Qualified Stock Option (right to buy) | Options Exercise | $0 | -4.5K | -100% | $0.00 | 0 | Oct 22, 2021 | Common Stock | 4.5K | $56.97 | Direct | F1, F2, F4 |
| transaction | ISRG | Non-Qualified Stock Option (right to buy) | Options Exercise | $0 | -3K | -86.58% | $0.00 | 465 | Oct 22, 2021 | Common Stock | 3K | $71.32 | Direct | F1, F2, F5 |
| Id | Content |
|---|---|
| F1 | These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on December 1, 2021. |
| F2 | On October 5, 2021, the common stock and equity grants of Intuitive Surgical split 3-for-1, resulting in the reporting person's ownership of the company's stock and equity grants to increase (for every one share owned or granted, 2 additional shares were issued) and the exercise price of stock option grants to decrease to 1/3rd of the original grant price. |
| F3 | The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $338.29 to $341.38 as follows: 1,400 shares sold at $338.19 to $338.98; 4,306 shares sold at $339.06 to $339.98; 1,594 shares sold at $340.01 to $340.83; 200 shares sold at $341 to $341.38. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. |
| F4 | Non-statutory stock option granted pursuant to the Non-Employee Directors' Stock Option Plan. Option shall vest 100% one year after the date of grant or at the next Shareholders Meeting, whichever should take place first, provided that vesting will cease on termination of the Directors service to the Company. |
| F5 | 100% of the shares subject to the option shall vest on the earlier of the one year anniversary of the date of grant or the next Annual Meeting of Stockholders, subject to the Reporting Person's continued service as a director to the issuer. |